eNauka - pregled

Pregled prema Autor Ciuleanu, Tudor E

Prikaz rezultata 1 do 5 od 5
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2020Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group AnalysisCufer, Tanja; Ciuleanu, Tudor E; Berzinec, Peter; Galffy, Gabriela; Jakopovic, Marko; Jassem, Jacek; Jovanovic, Dragana D; Mihaylova, Zhasmina; Ostoros, Gyula; Thallinger, Christiane;
Zemanova, Milada; Zielinski, Christoph;
Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2015Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trialThatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György;
Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2017Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)Pillai, Rathi N; Fennell, Dean; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Perin, Branislav M; Yalcin, Ilker; Teofilovici, Florentina;
Vukovic, Vojo M; Ramalingam, Suresh S;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2010Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.Ciuleanu, Tudor E; Samarzjia, M; Demidchik, Y; Beliakouski, V; Rancic, M; Bentsion, DL; Orlov, SV; Schaeffier, BA; De, Jager RL; Breitz, HBKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2)Pillai, Rathi N; Fennell, Dean A; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M;
Ramalingam, Suresh S;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+